Jordan · Delayed Price · Currency is JOD General Investment Statistics
Total Valuation
ASE:GENI has a market cap or net worth of JOD 28.30 million. The enterprise value is 27.68 million.
| Market Cap | 28.30M |
| Enterprise Value | 27.68M |
Important Dates
The next estimated earnings date is Sunday, February 15, 2026.
| Earnings Date | Feb 15, 2026 |
| Ex-Dividend Date | May 4, 2025 |
Share Statistics
ASE:GENI has 10.00 million shares outstanding.
| Current Share Class | 10.00M |
| Shares Outstanding | 10.00M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 19.26% |
| Owned by Institutions (%) | 5.98% |
| Float | 2.68M |
Valuation Ratios
The trailing PE ratio is 14.22.
| PE Ratio | 14.22 |
| Forward PE | n/a |
| PS Ratio | 2.41 |
| PB Ratio | 0.95 |
| P/TBV Ratio | 0.95 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 65.12 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.06, with an EV/FCF ratio of -1,009.30.
| EV / Earnings | 13.91 |
| EV / Sales | 2.36 |
| EV / EBITDA | 13.06 |
| EV / EBIT | 16.69 |
| EV / FCF | -1,009.30 |
Financial Position
The company has a current ratio of 4.01
| Current Ratio | 4.01 |
| Quick Ratio | 1.74 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 7.10% and return on invested capital (ROIC) is 4.83%.
| Return on Equity (ROE) | 7.10% |
| Return on Assets (ROA) | 3.35% |
| Return on Invested Capital (ROIC) | 4.83% |
| Return on Capital Employed (ROCE) | 5.56% |
| Weighted Average Cost of Capital (WACC) | 4.28% |
| Revenue Per Employee | 85,658 |
| Profits Per Employee | 14,524 |
| Employee Count | 137 |
| Asset Turnover | 0.38 |
| Inventory Turnover | 1.47 |
Taxes
In the past 12 months, ASE:GENI has paid 421,536 in taxes.
| Income Tax | 421,536 |
| Effective Tax Rate | 17.48% |
Stock Price Statistics
The stock price has decreased by -4.07% in the last 52 weeks. The beta is 0.01, so ASE:GENI's price volatility has been lower than the market average.
| Beta (5Y) | 0.01 |
| 52-Week Price Change | -4.07% |
| 50-Day Moving Average | 2.80 |
| 200-Day Moving Average | 2.83 |
| Relative Strength Index (RSI) | 46.33 |
| Average Volume (20 Days) | 5,537 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASE:GENI had revenue of JOD 11.74 million and earned 1.99 million in profits. Earnings per share was 0.20.
| Revenue | 11.74M |
| Gross Profit | 4.30M |
| Operating Income | 1.66M |
| Pretax Income | 2.41M |
| Net Income | 1.99M |
| EBITDA | 2.12M |
| EBIT | 1.66M |
| Earnings Per Share (EPS) | 0.20 |
Balance Sheet
The company has 623,893 in cash and n/a in debt, with a net cash position of 623,893 or 0.06 per share.
| Cash & Cash Equivalents | 623,893 |
| Total Debt | n/a |
| Net Cash | 623,893 |
| Net Cash Per Share | 0.06 |
| Equity (Book Value) | 29.81M |
| Book Value Per Share | 2.98 |
| Working Capital | 8.69M |
Cash Flow
In the last 12 months, operating cash flow was 434,572 and capital expenditures -461,993, giving a free cash flow of -27,421.
| Operating Cash Flow | 434,572 |
| Capital Expenditures | -461,993 |
| Free Cash Flow | -27,421 |
| FCF Per Share | -0.00 |
Margins
Gross margin is 36.66%, with operating and profit margins of 14.13% and 16.96%.
| Gross Margin | 36.66% |
| Operating Margin | 14.13% |
| Pretax Margin | 20.55% |
| Profit Margin | 16.96% |
| EBITDA Margin | 18.06% |
| EBIT Margin | 14.13% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.12, which amounts to a dividend yield of 4.24%.
| Dividend Per Share | 0.12 |
| Dividend Yield | 4.24% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 58.54% |
| Buyback Yield | n/a |
| Shareholder Yield | 4.24% |
| Earnings Yield | 7.03% |
| FCF Yield | -0.10% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ASE:GENI has an Altman Z-Score of 7.65 and a Piotroski F-Score of 5.
| Altman Z-Score | 7.65 |
| Piotroski F-Score | 5 |